Portola Pharmaceuticals Overview

Portola is dedicated to the discovery, development and commercialization of novel therapeutics for the prevention and treatment of cardiovascular disease. Portola has a highly experienced team focused in the areas of vascular thrombosis and inflammation. The company believes that its integrated approach to discovery, development and commercialization, applied to its comprehensive understanding of...More»

Portola is dedicated to the discovery, development and commercialization of novel therapeutics for the prevention and treatment of cardiovascular disease. Portola has a highly experienced team focused in the areas of vascular thrombosis and inflammation. The company believes that its integrated approach to discovery, development and commercialization, applied to its comprehensive understanding of platelet physiology and vascular thrombosis will result in new therapeutics where current therapies are inadequate. Portola's investors include Sutter Hill Ventures, Prospect Ventures, MPM Capital, Abingworth Management and Frazier Healthcare Ventures.«Less